NCT02677389

Brief Summary

This randomized pilot clinical trial studies how well survivorship care plan works in promoting technology-based physical activity in breast or colorectal cancer survivors in Wisconsin. A survivorship care plan may help doctors to better understand how they can help people who have been diagnosed with cancer to become more physically active. It is not yet known whether a standardized cancer survivor plan used as part of routine care or a technology-based physical activity intervention is better in promoting physical activity in breast or colorectal cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2018

Completed
Last Updated

November 18, 2019

Status Verified

February 1, 2019

Enrollment Period

1.6 years

First QC Date

February 1, 2016

Last Update Submit

November 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility as defined by recruitment rate

    Measures include recruitment rate (ability to recruit ≥5 patients per month to the study), retention rate (ability to collect all measures on ≥80% of randomized patients) and patient satisfaction with SCP, Fitbit, and physical activity intervention materials, both overall and by cancer type (breast/colon).

    Up to 12 weeks

Secondary Outcomes (2)

  • Physical activity as measured by the ActiGraph GT3X+ accelerometer (Arm I)

    Up to 12 weeks

  • Physical activity as measured by the ActiGraph GT3X+ accelerometer (Arm II)

    Up to 12 weeks

Study Arms (2)

Arm I (Enhanced SCP)

EXPERIMENTAL

See Detailed Description

Other: Educational InterventionOther: Internet-Based InterventionDevice: Monitoring DeviceOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Arm II (SCP)

ACTIVE COMPARATOR

Participants receive a standard SCP, comprised of a treatment and follow up recommendations, including basic physical activity guidance, copy of the USDA Dietary Guidelines for Americans, as well as standardized emails with wellness tips and information on stress management provided from the American Heart Association's website on "Healthy Habits" at 1, 2, 4, and 8 weeks. Specific topics in emails include "positive self-talk", "daily relaxation breathing techniques", "better sleep", and "ways to find pleasure".

Other: Educational InterventionOther: Quality-of-Life AssessmentOther: Questionnaire Administration

Interventions

Receive educational material regarding physical activity and standardized emails with wellness tips and information on stress management

Also known as: Education for Intervention, Intervention, Educational
Arm I (Enhanced SCP)Arm II (SCP)

Receive email and technical or how-to support from study coordinator

Arm I (Enhanced SCP)

Wear a Fitbit web-integrated physical activity tracker

Also known as: Monitor, Fitbit
Arm I (Enhanced SCP)

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (Enhanced SCP)Arm II (SCP)

Ancillary studies

Arm I (Enhanced SCP)Arm II (SCP)

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CRITERIA FOR SURVIVORS:
  • Have a diagnosis of stage I-III female breast cancer or colorectal cancer within the past 5 years; bilateral or multiple primary breast cancers are permitted; individuals who have had more than one type of cancer (e.g., both breast and melanoma) are permitted as long as the breast (or colorectal) diagnosis meets the other criteria and primary treatment for any cancer is not ongoing
  • Have completed primary treatment for their cancer; primary treatment will be defined as having completed all (a) definitive cancer surgery, (b) (neo)adjuvant chemotherapy, and/or (c) (neo)adjuvant radiation; breast cancer patients still receiving adjuvant endocrine or human epidermal growth factor receptor 2 (HER2) targeted therapies are eligible, as would colon cancer patients receiving a targeted agent; if there is any question whether a patient meets this eligibility requirement, Dr. Tevaarwerk (co-I, Oncology) will adjudicate
  • Are willing to attempt increase in physical activity level
  • Have a co-survivor (friend or family member) willing to participate in this research study
  • ELIGIBILITY CRITERIA FOR BOTH SURVIVORS AND CO-SURVIVORS:
  • Have high-speed access to the internet at home or work; This could be broadband, digital subscriber line (DSL), and/or access on a smartphone or tablet via a wireless provider
  • Fluent in English
  • Willing and able to attend study visits at the University of Wisconsin (UW) - Madison
  • Co-survivors must be over the age of 18 years

You may not qualify if:

  • Survivors must not have evidence of recurrent or metastatic disease
  • Survivors must not have previously received an SCP or are unwilling to receive one
  • Survivors must not be performing \>= 100 minute (min)/week of moderate-vigorous physical activity
  • Conditions that would interfere with the safety of moderate-to-vigorous intensity physical activity; participants will be screened for safety using the validated Physical Activity Readiness Questionnaire (PAR-Q)
  • Any physical or mental health condition that would interfere with full participation in the study, including individuals who are unable to read consent materials or appear to lack the capacity to consent
  • Any individual considered to be that of a "vulnerable group", including pregnant women and prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin Carbone Cancer Center

Madison, Wisconsin, 53792, United States

Location

Related Publications (1)

  • Rastogi S, Tevaarwerk AJ, Sesto M, Van Remortel B, Date P, Gangnon R, Thraen-Borowski K, Cadmus-Bertram L. Effect of a technology-supported physical activity intervention on health-related quality of life, sleep, and processes of behavior change in cancer survivors: A randomized controlled trial. Psychooncology. 2020 Nov;29(11):1917-1926. doi: 10.1002/pon.5524. Epub 2020 Oct 4.

Related Links

MeSH Terms

Conditions

Colorectal NeoplasmsBreast Neoplasms

Interventions

Early Intervention, EducationalEducational StatusMethodsMonitoring, Physiologic

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Child Health ServicesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesPreventive Health ServicesSocioeconomic FactorsPopulation CharacteristicsInvestigative TechniquesDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Lisa Cadmus-Bertram

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2016

First Posted

February 9, 2016

Study Start

July 1, 2016

Primary Completion

January 24, 2018

Study Completion

January 24, 2018

Last Updated

November 18, 2019

Record last verified: 2019-02

Locations